ImprimisRx NJ recalls Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
Recalled November 23, 2022 · FDA recall D-0060-2023 · ImprimisRx NJ
Hazard
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost. · FDA Class II
Units
960 bottles
Sold at
Nationwide in the USA
Description
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
Product
Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
Manufacturer(s)
ImprimisRx NJ
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →